Semaglutide and Weight-Loss Injections: Can They Help Psoriasis?

Semaglutide (Ozempic, Wegovy and the new Indian generics) is not a psoriasis medicine and is not approved for psoriasis anywhere. But for people who have psoriasis and obesity or type 2 diabetes, early studies suggest that these weight-loss injections may help psoriasis improve alongside the weight loss. The evidence is promising but still small, so this is a conversation to have with your dermatologist and diabetes doctor together, not a reason to start an injection on your own. For the bigger picture of psoriasis medicines, see our guide to biologics and treatment classes.

What is semaglutide, and why are dermatologists talking about it?

Semaglutide belongs to a group called GLP-1 receptor agonists. It copies a gut hormone that helps control blood sugar and makes you feel full sooner. It is sold as a weekly injection (Ozempic for diabetes, Wegovy for weight management) and in tablet form. Tirzepatide (Mounjaro/Zepbound) is a related medicine that acts on two hormones, GLP-1 and GIP.

Dermatologists became interested for two reasons. First, psoriasis and excess weight are closely linked. Fat tissue, especially around the belly, releases inflammatory signals, and people with a higher body weight often have more severe psoriasis and respond less well to some treatments. Second, doctors treating patients for diabetes or obesity noticed that some patients' skin improved too.

We have written before about the research-backed link between weight and psoriasis and about psoriasis and diabetes. These are very relevant in India, where diabetes and central obesity are common even in people who don't look heavy.

What does the research actually show?

Small studies: encouraging, but limited

In 2026, the US National Psoriasis Foundation's Medical Board published a review in JAMA Dermatology looking at GLP-1 medicines in psoriasis. Across small studies of 7 to 48 people, lasting up to six months, PASI scores fell by about 40% to 80%. Inflammation markers such as CRP and IL-6 also came down, along with belly fat and cholesterol problems. The authors were clear that the evidence comes mostly from small, short studies, many without a control group, and that larger randomised trials are needed. [1]

One example is a six-month study from Spain of 43 adults with obesity and moderate-to-severe plaque psoriasis (without diabetes). With weekly semaglutide plus lifestyle advice, PASI fell by an average of 48%, and mood and quality of life improved. Interestingly, skin improvement tracked most closely with loss of fat just under the skin, not simply with total kilos lost. [2] Again, there was no comparison group, so we cannot tell how much of this was due to the drug itself.

The first big randomised trial used a combination

The strongest evidence so far is the TOGETHER-PsO trial, a phase 3b randomised study in adults with moderate-to-severe psoriasis and obesity (average BMI above 39). Everyone received the biologic ixekizumab; half also received tirzepatide. At 36 weeks, 27.1% of the combination group had both completely clear skin (PASI 100) and at least 10% weight loss, compared with 5.8% on ixekizumab alone. Complete clearance by itself was reached by 40.6% versus 29.0%. [3]

Notice what this trial tested: a weight-loss medicine added to a proven psoriasis biologic. It does not show that a weight-loss injection alone can replace psoriasis treatment.

Weight loss itself matters

Older research supports the idea that losing weight helps. In a Danish randomised study of 60 overweight people with psoriasis, a strict low-calorie diet led to about 15 kg more weight loss than usual eating. Psoriasis severity showed a trend towards improvement (not quite statistically significant), and quality of life improved significantly. [4] So part of what GLP-1 medicines do for psoriasis may simply be the weight loss, and part may be a direct effect on inflammation. Researchers are still working this out.

Who might benefit, and who probably won't

Based on current evidence, the people most likely to discuss a GLP-1 medicine with their doctors are adults who have:

• Psoriasis plus obesity, or overweight with a weight-related problem such as high blood pressure or fatty liver
• Psoriasis plus type 2 diabetes, where semaglutide may already be a reasonable diabetes choice
• Psoriasis that responds poorly to treatment, where excess weight may be part of the reason

It is not a sensible option for people of normal weight who simply want clearer skin, for teenagers without a specialist's advice, or during pregnancy. There is currently no good evidence that it helps psoriasis in people who don't have obesity or diabetes.

Psoriasis also raises the risk of heart disease, which is another reason weight and blood sugar deserve attention. Read more in psoriasis and cardiovascular risk.

Semaglutide in India: cost, availability and caution

Semaglutide's patent in India expired on 20 March 2026. Within days, several Indian companies, including Dr Reddy's, Sun Pharma, Glenmark, Alkem, Zydus, Natco and Eris, launched generic versions. Reported monthly prices ranged from about ₹1,300 for vial-based versions to around ₹4,200 for a pre-filled pen, with some higher doses costing more. [5] Novo Nordisk then cut the price of the starting dose of Ozempic and Wegovy to about ₹1,415 a week from 1 April 2026. [6] Prices vary by brand, dose and city, so check with your pharmacist.

Lower prices are good news for people with diabetes and obesity, but they also make misuse easier. Please keep these points in mind:

• It is a prescription medicine. The dose has to be increased slowly, and your doctor needs to check your blood sugar, other medicines and medical history.
• Buy only from a licensed pharmacy. Avoid "slimming injections" sold on social media or at beauty clinics.
• Tell every doctor. Your dermatologist, physician and any Ayurvedic doctor should know you are on it.
• Be careful with herbal weight-loss powders and kadhas taken alongside. Some herbs, such as giloy, have been linked in published reports from India to liver injury in susceptible people, and pregnant women and children should not take herbal mixtures without medical advice.

Side effects to know about

The most common side effects are nausea, vomiting, constipation, diarrhoea, tiredness and redness or itching at the injection site. Hair thinning can also happen. Less common but serious problems include inflammation of the pancreas (severe stomach pain spreading to the back), gallbladder problems, low blood sugar (especially with other diabetes medicines), worsening diabetic eye disease and allergic reactions. [7]

Semaglutide is not used in pregnancy or while breastfeeding, and women planning a pregnancy are advised to stop it at least two months beforehand. [7] The NPF review found these drugs appear to work alongside methotrexate, cyclosporine and biologics, with stomach upset being the main problem. [1]

Rapid weight loss can also mean eating very little. With psoriasis, it is important to keep getting enough protein, fruit and vegetables. A dietitian can help you plan simple Indian meals that fit.

Your psoriasis care still matters

Even if you and your doctors decide a GLP-1 medicine makes sense, it sits on top of your normal psoriasis care, not instead of it:

• Keep taking your prescribed treatment. Topical steroids, vitamin D creams, phototherapy, methotrexate and biologics all have a real place under a doctor's care. Do not stop or reduce them without your dermatologist's advice.
• Moisturise every day. Dryness and scaling are common, and nausea or eating less can leave skin drier. Gentle, fragrance-conscious moisturisers and oils may help soothe dryness and itching. You can explore options in our body psoriasis care collection.
• Drink enough water, especially in Indian summers and if you have vomiting or diarrhoea.
• Move your body. Walking, yoga or swimming support weight loss and help with stress, a known psoriasis trigger.

When to see a doctor

See your dermatologist or physician promptly, or go to the nearest hospital emergency department, if you notice:

• Severe stomach pain, especially if it spreads to your back, with or without vomiting
• Vomiting or diarrhoea that stops you keeping fluids down, or signs of dehydration such as dizziness and very little urine
• Shakiness, sweating and confusion (possible low blood sugar), particularly if you also take insulin or sulfonylurea tablets
• Pain in the upper right abdomen, yellow eyes or dark urine
• Sudden changes in vision
• Psoriasis spreading quickly over large areas, skin turning red all over, or pus-filled bumps with fever
• Swelling of the face, lips or throat, or difficulty breathing

Also book a regular appointment if your psoriasis is not improving on your current treatment, or if you want to discuss weight and diabetes as part of your psoriasis care. Many large hospitals in India have dermatology and endocrinology departments that can work together.

Frequently asked questions

Can semaglutide cure psoriasis?

No. Psoriasis is a long-term condition, and semaglutide is not approved for it. In people with obesity or diabetes, small studies suggest it may help psoriasis improve, likely through weight loss and lower inflammation.

Can I take Ozempic or Wegovy with my biologic or methotrexate?

Current evidence suggests GLP-1 medicines can be used alongside methotrexate, cyclosporine and biologics, but your doctors must decide this together and monitor you.

How much does generic semaglutide cost in India?

After the patent expired in March 2026, reported prices ranged from about ₹1,300 to ₹4,200 a month for common starting doses, with higher doses costing more. Prices change, so confirm with your pharmacist.

I am not overweight. Will semaglutide help my psoriasis?

There is no good evidence for this. The studies so far involved people with obesity or diabetes, and using it without a medical reason exposes you to side effects without a clear benefit.

Is tirzepatide (Mounjaro) better than semaglutide for psoriasis?

No direct comparison exists. The largest trial so far tested tirzepatide added to a biologic, not on its own, so it is too early to say one is better.

Sources

1. Sheth S, Merola JF, Weber BN, et al. GLP-1 receptor agonists in psoriasis (National Psoriasis Foundation Medical Board review). JAMA Dermatology, 2026. doi:10.1001/jamadermatol.2026.0859. Summary: Practical Dermatology
2. Nicolau J, Nadal A, Sanchís P, et al. Dermatological and metabolic benefits of semaglutide in psoriasis with obesity: a 6-month prospective cohort study. Clinical and Experimental Dermatology, 2025
3. TOGETHER-PsO: combination ixekizumab and tirzepatide in psoriasis with obesity. Practical Dermatology, February 2026
4. Jensen P, Zachariae C, Christensen R, et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatology, 2013
5. Generic semaglutide price war in India after patent expiry. ThePrint, 21 March 2026
6. Novo Nordisk cuts prices of Ozempic and Wegovy in India. Deccan Chronicle, 31 March 2026
7. Semaglutide: side effects, who can take it, pregnancy. NHS (UK)

This article is for general information and is not medical advice. Please consult a qualified dermatologist or Ayurvedic doctor for diagnosis and treatment.